| 释义 |
Phase 3b Phase 3b The period of time between submission for approval of a new drug and receipt of marketing authorisation.
Phase 3B A subcategory of a Phase-3 clinical trial, performed near the time of approval to accumulate additional findings which and may be required as a condition of regulatory authority approval. Dossier review may continue while associated Phase-3B trials are conducted. |